<DOC>
	<DOCNO>NCT01656070</DOCNO>
	<brief_summary>Along effect bone metabolism , vitamin D important modulator immune system . Experimental study show active metabolite vitamin D [ 1,25 ( OH ) 2D ] able skew T cell compartment anti-inflammatory state , inhibition Th1 Th17 cell promotion Th2 T regulatory subset . In context HIV infection , Th1 subpopulation devote inhibit viral replication , alteration Th1/Th2 balance would concern . The aim Randomized Controlled Trial test wether oral supplementation cholecalciferol could able : 1 ) improve vitamin D status , 2 ) play immunomodulatory role , vertically HIV-infected child young adult hypovitaminosis D .</brief_summary>
	<brief_title>Vitamin D Supplementation HIV-infected Youth</brief_title>
	<detailed_description>There increase evidence hypovitaminosis D common general population . Low dietary intake vitamin D reduce exposure sunlight probably major risk factor . A high prevalence hypovitaminosis D describe HIV-infected adult , child . HIV infection antiretroviral ( ARV ) treatment may responsible alteration vitamin D metabolism . For instance , study show significant decrease serum 25-hydroxyvitamin-D [ 25 ( OH ) D ] concentration adult receive non-nucleoside reverse transcriptase inhibitor ( NNRTIs ) . Whatever cause ( ) hypovitaminosis D , importance vitamin D bone health , randomize control trial ( RCT ) perform test whether vitamin D supplementation improve vitamin D status bone mineral metabolism HIV-infected child adolescent . Along effect bone metabolism , vitamin D important modulator immune system . The vitamin D receptor ( VDR ) find high concentration activate T lymphocyte , small amount monocyte/macrophage cell B lymphocytes contain detectable amount VDR . Experimental study show active di-hydroxylated metabolite vitamin D [ 1,25 ( OH ) 2D ] able skew T cell compartment anti-inflammatory state , inhibition Th1 Th17 cell promotion Th2 T regulatory ( Treg ) subset . In context HIV infection , Th1 subpopulation devote inhibit viral replication , 16 alteration Th1/Th2 balance would concern . Although biological effect vitamin D mediate 1,25 ( OH ) 2D , 25 ( OH ) D routinely quantify long half-life.17 However , HIV-infected subject may defective 1α-hydroxylation 25 ( OH ) D. Thus , important evaluate effect vitamin D supplementation term 25 ( OH ) D 1,25 ( OH ) 2D response . This repeated-measures parallel-group RCT aim test wether 12-month oral supplementation cholecalciferol ( vitamin D3 ) able : 1 ) increase serum 25 ( OH ) D 1,25 ( OH ) 2D level , 2 ) affect T-cell phenotype vertically HIV-infected child young adult hypovitaminosis D stable HIV-disease . Main outcome : determine frequency hypovitaminosis D 12-month follow-up among subject supplement oral cholecalciferol versus subject receive placebo . Secondary outcome : investigate correlation - - serum vitamin D concentration marker immune activation ( i.e . Th1- , Th2- , Th17- Treg-lymphocytes count , T-lymphocyte VDR expression )</detailed_description>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Avitaminosis</mesh_term>
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Vertically acquire HIV infection age &lt; 30 year serum 25 ( OH ) D concentration &lt; 30 ng/mL sign write informed consent hyperparathyroidism , detect intact serum parathyroid hormone ( PTH ) ≥ 65 pg/mL Black ethnic group supplementation vitamin D previous 12 month use treatment know alter vitamin D status previous 6 month ( exclude ARV ) concomitant severe illness .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>HIV</keyword>
	<keyword>child</keyword>
	<keyword>adolescent</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>immunity</keyword>
	<keyword>T cell phenotype</keyword>
</DOC>